喹诺酮类药物的药效学 - Suppr | 超能文献

Pharmacodynamics of quinolones.

作者信息

Dalhoff A

机构信息

Bayer AG, Pharma Research Centre, Institute for Chemotherapy, Wuppertal, Germany.

出版信息

Drugs. 1995;49 Suppl 2:197-9. doi: 10.2165/00003495-199500492-00040.

DOI:10.2165/00003495-199500492-00040

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Pharmacodynamics of quinolones.喹诺酮类药物的药效学

Drugs. 1995;49 Suppl 2:197-9. doi: 10.2165/00003495-199500492-00040.

2

In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.新型氟喹诺酮类药物E-3846对革兰氏阴性菌和革兰氏阳性菌的体外活性

Chemioterapia. 1987 Jun;6(2 Suppl):149-51.

3

[The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].

Antibiot Khimioter. 1998;43(2):30-9.

4

Potent non-6-fluoro-substituted quinolone antibacterials: synthesis and biological activity.

J Med Chem. 1992 Jan;35(1):198-200. doi: 10.1021/jm00079a028.

5

In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.三种非氟喹诺酮类药物对代表性细菌分离株的体外活性。

Antimicrob Agents Chemother. 2001 Jun;45(6):1923-7. doi: 10.1128/AAC.45.6.1923-1927.2001.

6

The antimicrobial activity of sparfloxacin, a new quinolone.新喹诺酮类药物司帕沙星的抗菌活性

Drugs. 1995;49 Suppl 2:238-9. doi: 10.2165/00003495-199500492-00054.

7

In vitro activity of the active metabolite of prulifloxacin (AF 3013) compared with six other fluoroquinolones.普鲁利沙星活性代谢物（AF 3013）与其他六种氟喹诺酮类药物的体外活性比较。

Eur J Clin Microbiol Infect Dis. 2002 Apr;21(4):328-34. doi: 10.1007/s10096-002-0709-1. Epub 2002 Apr 19.

8

[In vitro evaluation of lomefloxacin].[洛美沙星的体外评价]

Arzneimittelforschung. 1989 Aug;39(8):832-5.

9

Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg?染色体回旋酶基因突变导致的喹诺酮耐药性。这只是冰山一角吗？

J Antimicrob Chemother. 1998 Dec;42(6):683-8. doi: 10.1093/jac/42.6.683.

10

[In vitro and in vivo antibacterial activities of a new quinolone derivative, FD501].

Jpn J Antibiot. 1996 Mar;49(3):264-72.

引用本文的文献

1

Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.非那沙星、环丙沙星和左氧氟沙星在血清和尿液中对尿路感染患者分离出的产TEM型和SHV型超广谱β-内酰胺酶肠杆菌科细菌的药效学研究

Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02446-16. Print 2017 May.

2

A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities.动态模型中抗生素体外比较的新方法：曲线下等效面积/MIC断点以及曲伐沙星和环丙沙星针对相似敏感性细菌的等效剂量

Antimicrob Agents Chemother. 1998 Nov;42(11):2841-7. doi: 10.1128/AAC.42.11.2841.